Yanimo Respimat 2.5 µg/dose - 2.5 µg/dose inhal. sol. cartr.

Land: Belgien

Sprache: Englisch

Quelle: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Wirkstoff:

Tiotropium Bromide Monohydrate 3,1 µg/dose - Eq. Tiotropium 2,5 µg/dose; Olodaterol Hydrochloride 2,7 µg/dose - Eq. Olodaterol 2,5 µg/dose

Verfügbar ab:

Boehringer Ingelheim International GmbH

ATC-Code:

R03AL06

INN (Internationale Bezeichnung):

Tiotropium Bromide Monohydrate; Olodaterol Hydrochloride

Dosierung:

2,5 µg/dose - 2,5 µg/dose

Darreichungsform:

Inhalation solution

Zusammensetzung:

Tiotropium Bromide Monohydrate 3.1 µg/dose; Olodaterol Hydrochloride 2.7 µg/dose

Verabreichungsweg:

Inhalation use

Therapiebereich:

Olodaterol and Tiotropiumbromide

Produktbesonderheiten:

CTI code: 475102-02 - Pack size: 2 x 60 doses (4 (4) + 2 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-03 - Pack size: 3 x 60 doses (4 (4) + 3 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-01 - Pack size: 60 doses (4 (4) + 1 x Inhaler - Commercialisation status: YES - FMD code: 04048846017543 - CNK code: 3690997 - Delivery mode: Medical prescription; CTI code: 475102-06 - Pack size: 3 x 60 doses (4 (4) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-07 - Pack size: 3 x 60 doses (4 (4) + 1 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-04 - Pack size: 8 x 60 doses (4 (4) + 8 x Inhaler - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 475102-05 - Pack size: 60 doses (4 (4) - Commercialisation status: NO - Delivery mode: Medical prescription

Berechtigungsstatus:

Commercialised: Yes

Berechtigungsdatum:

2015-06-22